{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:33:55Z","timestamp":1792359235010,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81895-w","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T02:33:51Z","timestamp":1735353231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of plasma BDNF and MMP-9 levels with mild cognitive impairment: a matched case-control study"],"prefix":"10.1038","volume":"14","author":[{"given":"Tingyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"81895_CR1","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 19, 1598\u20131695 (2023).","DOI":"10.1002\/alz.13016"},{"key":"81895_CR2","doi-asserted-by":"publisher","first-page":"22666","DOI":"10.18632\/aging.203598","volume":"13","author":"TKS Ng","year":"2021","unstructured":"Ng, T. K. S. et al. Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study. Aging (Albany NY). 13, 22666\u201322689 (2021).","journal-title":"Aging (Albany NY)"},{"key":"81895_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12877-019-1175-2","volume":"19","author":"RX Jia","year":"2019","unstructured":"Jia, R. X., Liang, J. H., Xu, Y. & Wang, Y. Q. Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis. BMC Geriatr. 19, 181 (2019).","journal-title":"BMC Geriatr."},{"key":"81895_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12944-016-0344-y","volume":"15","author":"Q Liu","year":"2016","unstructured":"Liu, Q. et al. Relationship between oxysterols and mild cognitive impairment in the elderly: a case-control study. Lipids Health Dis. 15, 177 (2016).","journal-title":"Lipids Health Dis."},{"key":"81895_CR5","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack, C. R. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"81895_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","volume":"11","author":"AA Tahami Monfared","year":"2022","unstructured":"Tahami Monfared, A. A., Byrnes, M. J., White, L. A. & Zhang, Q. Alzheimer\u2019s disease: Epidemiology and clinical progression. Neurol. Ther. 11, 553\u2013569 (2022).","journal-title":"Neurol. Ther."},{"key":"81895_CR7","doi-asserted-by":"publisher","first-page":"1336385","DOI":"10.3389\/fneur.2024.1336385","volume":"15","author":"S Rao","year":"2024","unstructured":"Rao, S. et al. Prevalence, cognitive characteristics, and influencing factors of amnestic mild cognitive impairment among older adults residing in an urban community in Chengdu, China. Front. Neurol. 15, 1336385 (2024).","journal-title":"Front. Neurol."},{"key":"81895_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2147\/CIA.S73922","volume":"10","author":"SA Eshkoor","year":"2015","unstructured":"Eshkoor, S. A., Hamid, T. A., Mun, C. Y. & Ng, C. K. Mild cognitive impairment and its management in older people. Clin. Interv Aging. 10, 687\u2013693 (2015).","journal-title":"Clin. Interv Aging"},{"key":"81895_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183\u2013194 (2004).","journal-title":"J. Intern. Med."},{"key":"81895_CR10","doi-asserted-by":"publisher","first-page":"e2200576","DOI":"10.1002\/mnfr.202200576","volume":"67","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. The Interaction Effect of 27-Hydroxycholesterol metabolism disorder and CYP27A1 single nucleotide polymorphisms in mild cognitive impairment: evidence from a case-control study. Mol. Nutr. Food Res. 67, e2200576 (2023).","journal-title":"Mol. Nutr. Food Res."},{"key":"81895_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13668-019-0271-4","volume":"8","author":"AM McGrattan","year":"2019","unstructured":"McGrattan, A. M. et al. Diet and inflammation in cognitive ageing and Alzheimer\u2019s Disease. Curr. Nutr. Rep. 8, 53\u201365 (2019).","journal-title":"Curr. Nutr. Rep."},{"key":"81895_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/00207454.2012.762515","volume":"123","author":"N Sonali","year":"2013","unstructured":"Sonali, N., Tripathi, M., Sagar, R. & Vivekanandhan, S. Val66Met polymorphism and BDNF levels in Alzheimer\u2019s disease patients in north Indian population. Int. J. Neurosci. 123, 409\u2013416 (2013).","journal-title":"Int. J. Neurosci."},{"key":"81895_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cger.2017.02.005","volume":"33","author":"AM Sanford","year":"2017","unstructured":"Sanford, A. M. Mild cognitive impairment. Clin. Geriatr. Med. 33, 325\u2013337 (2017).","journal-title":"Clin. Geriatr. Med."},{"key":"81895_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13195-024-01555-z","volume":"16","author":"AH Dyer","year":"2024","unstructured":"Dyer, A. H. et al. Performance of plasma p-tau217 for the detection of amyloid-\u03b2 positivity in a memory clinic cohort using an electrochemiluminescence immunoassay. Alzheimer\u2019s Res. Therapy. 16, 186 (2024).","journal-title":"Alzheimer\u2019s Res. Therapy"},{"key":"81895_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/d41586-024-02535-x","volume":"632","author":"A Abbott","year":"2024","unstructured":"Abbott, A. Blood tests could soon predict your risk of Alzheimer\u2019s. Nature 632, 243\u2013245 (2024).","journal-title":"Nature"},{"key":"81895_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41598-024-51334-x","volume":"14","author":"P Kivis\u00e4kk","year":"2024","unstructured":"Kivis\u00e4kk, P. et al. Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer\u2019s disease. Sci. Rep. 14, 629 (2024).","journal-title":"Sci. Rep."},{"key":"81895_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","volume":"11","author":"L Gao","year":"2022","unstructured":"Gao, L., Zhang, Y., Sterling, K. & Song, W. Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential. Transl Neurodegener. 11, 4 (2022).","journal-title":"Transl Neurodegener"},{"issue":"Suppl 1","key":"81895_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1017\/S0317167100005618","volume":"34","author":"P Bailey","year":"2007","unstructured":"Bailey, P. Biological markers in Alzheimer\u2019s disease. Can. J. Neurol. Sci. 34 (Suppl 1), 72\u201376 (2007).","journal-title":"Can. J. Neurol. Sci."},{"key":"81895_CR19","doi-asserted-by":"crossref","unstructured":"Azman, K. F. & Zakaria, R. Recent advances on the role of brain-derived neurotrophic factor (BDNF) in neurodegenerative diseases. Int. J. Mol. Sci. 23, (2022).","DOI":"10.3390\/ijms23126827"},{"key":"81895_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/00207454.2019.1667794","volume":"130","author":"B Xie","year":"2020","unstructured":"Xie, B. et al. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer\u2019s disease and mild cognitive impairment: results of a meta-analysis. Int. J. Neurosci. 130, 218\u2013230 (2020).","journal-title":"Int. J. Neurosci."},{"key":"81895_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.psychres.2019.02.051","volume":"274","author":"YJ Chiou","year":"2019","unstructured":"Chiou, Y. J. & Huang, T. L. Brain-derived neurotrophic factor (BDNF) and bipolar disorder. Psychiatry Res. 274, 395\u2013399 (2019).","journal-title":"Psychiatry Res."},{"key":"81895_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13195-022-01106-4","volume":"14","author":"AA Tsiknia","year":"2022","unstructured":"Tsiknia, A. A. et al. Sex differences in Alzheimer\u2019s disease: plasma MMP-9 and markers of disease severity. Alzheimers Res. Ther. 14, 160 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"81895_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1017\/S0954579420002102","volume":"34","author":"JR Lord","year":"2022","unstructured":"Lord, J. R., Mashayekhi, F. & Salehi, Z. How matrix metalloproteinase (MMP)-9 (rs3918242) polymorphism affects MMP-9 serum concentration and associates with autism spectrum disorders: a case-control study in Iranian population. Dev. Psychopathol. 34, 882\u2013888 (2022).","journal-title":"Dev. Psychopathol."},{"key":"81895_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/08039488.2019.1658126","volume":"73","author":"J Arabska","year":"2019","unstructured":"Arabska, J., Margulska, A., Strzelecki, D. & Wysoki\u0144ski, A. Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia? Nord J. Psychiatry. 73, 515\u2013521 (2019).","journal-title":"Nord J. Psychiatry"},{"key":"81895_CR25","doi-asserted-by":"crossref","unstructured":"Ve\u010durkovsk\u00e1, I. et al. Stage-Dependent Levels of Brain-Derived Neurotrophic Factor and Matrix Metalloproteinase 9 in the Prognosis of Colorectal Cancer. Biomedicines 11, (2023).","DOI":"10.3390\/biomedicines11071839"},{"key":"81895_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","volume":"7","author":"CD Whelan","year":"2019","unstructured":"Whelan, C. D. et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease. Acta Neuropathol. Commun. 7, 169 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"81895_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jalz.2013.11.002","volume":"11","author":"D Ding","year":"2015","unstructured":"Ding, D. et al. Prevalence of mild cognitive impairment in an urban community in China: a cross-sectional analysis of the Shanghai Aging Study. Alzheimers Dement. 11, 300\u2013309e2 (2015).","journal-title":"Alzheimers Dement."},{"key":"81895_CR28","first-page":"404","volume":"22","author":"RC Petersen","year":"2016","unstructured":"Petersen, R. C. Mild cognitive impairment. Continuum (Minneap Minn). 22, 404\u2013418 (2016).","journal-title":"Continuum (Minneap Minn)"},{"key":"81895_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11010-023-04733-z","volume":"479","author":"CA De S\u00e1","year":"2024","unstructured":"De S\u00e1, C. A. et al. Effects of a physical exercise or motor activity protocol on cognitive function, lipid profile, and BDNF levels in older adults with mild cognitive impairment. Mol. Cell. Biochem. 479, 499\u2013509 (2024).","journal-title":"Mol. Cell. Biochem."},{"key":"81895_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/23279095.2020.1778477","volume":"29","author":"J An","year":"2022","unstructured":"An, J. et al. Cognition in chronic kidney disease patients: evaluation with the Beijing version of the Montreal Cognitive Assessment. Appl. Neuropsychol. Adult. 29, 520\u2013526 (2022).","journal-title":"Appl. Neuropsychol. Adult"},{"key":"81895_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.12740\/PP\/45368","volume":"50","author":"N Ciesielska","year":"2016","unstructured":"Ciesielska, N. et al. Is the Montreal cognitive assessment (MoCA) test better suited than the Mini-mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 50, 1039\u20131052 (2016).","journal-title":"Psychiatr Pol."},{"key":"81895_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gps.4756","volume":"33","author":"N Carson","year":"2018","unstructured":"Carson, N., Leach, L. & Murphy, K. J. A re-examination of Montreal cognitive assessment (MoCA) cutoff scores. Int. J. Geriatr. Psychiatry. 33, 379\u2013388 (2018).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"81895_CR33","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.3390\/nu14235102","volume":"14","author":"A Kaddoumi","year":"2022","unstructured":"Kaddoumi, A. et al. Extra-virgin Olive Oil enhances the blood-brain barrier function in mild cognitive impairment: a Randomized Controlled Trial. Nutrients 14, 5102 (2022).","journal-title":"Nutrients"},{"key":"81895_CR34","unstructured":"Growth patterns of activity of. Daily living disability and associated factors among the Chinese elderly: a twelve-year longitudinal study - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/34902707\/"},{"key":"81895_CR35","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1212\/WNL.0b013e318288690c","volume":"80","author":"SJB Vos","year":"2013","unstructured":"Vos, S. J. B. et al. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology 80, 1124\u20131132 (2013).","journal-title":"Neurology"},{"key":"81895_CR36","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1007\/s10571-023-01401-0","volume":"43","author":"A Mobed","year":"2023","unstructured":"Mobed, A. et al. Recent advances in determination of BDNF and NfL. Cell. Mol. Neurobiol. 43, 3801\u20133814 (2023). Biosensors.","journal-title":"Cell. Mol. Neurobiol."},{"key":"81895_CR37","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1038\/s41467-021-24810-5","volume":"12","author":"S Martinelli","year":"2021","unstructured":"Martinelli, S. et al. Stress-primed secretory autophagy promotes extracellular BDNF maturation by enhancing MMP9 secretion. Nat. Commun. 12, 4643 (2021).","journal-title":"Nat. Commun."},{"key":"81895_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpsychires.2014.10.003","volume":"60","author":"KL Szuhany","year":"2015","unstructured":"Szuhany, K. L., Bugatti, M. & Otto, M. W. A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. J. Psychiatr Res. 60, 56\u201364 (2015).","journal-title":"J. Psychiatr Res."},{"key":"81895_CR39","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1523\/JNEUROSCI.2273-21.2022","volume":"42","author":"G Bastioli","year":"2022","unstructured":"Bastioli, G. et al. Voluntary Exercise boosts striatal dopamine release: evidence for the necessary and sufficient role of BDNF. J. Neurosci. 42, 4725\u20134736 (2022).","journal-title":"J. Neurosci."},{"key":"81895_CR40","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1139\/apnm-2018-0192","volume":"43","author":"JJ Walsh","year":"2018","unstructured":"Walsh, J. J. & Tschakovsky, M. E. Exercise and circulating BDNF: mechanisms of release and implications for the design of exercise interventions. Appl. Physiol. Nutr. Metab. 43, 1095\u20131104 (2018).","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"81895_CR41","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.yfrne.2021.100971","volume":"65","author":"K Seidler","year":"2022","unstructured":"Seidler, K. & Barrow, M. Intermittent fasting and cognitive performance - targeting BDNF as potential strategy to optimise brain health. Front. Neuroendocrinol. 65, 100971 (2022).","journal-title":"Front. Neuroendocrinol."},{"key":"81895_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrn.2017.156","volume":"19","author":"MP Mattson","year":"2018","unstructured":"Mattson, M. P., Moehl, K., Ghena, N., Schmaedick, M. & Cheng, A. Intermittent metabolic switching, neuroplasticity and brain health. Nat. Rev. Neurosci. 19, 63\u201380 (2018).","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81895-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T16:05:41Z","timestamp":1735401941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81895-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81895"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81895-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committees of Shihezi People\u2019s Hospital under the Declaration of Helsinki (KJ-2023-06). All participants included in the study were informed about the aims and methods of the study and provided their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30911"}}